Lannett Company, Inc.
(NYSE : LCI)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc.
-0.94%43.120.9%$1078.21m
MRKMerck & Co., Inc.
0.01%74.790.6%$1075.03m
JNJJohnson & Johnson
-3.01%142.040.6%$1046.82m
ABBVAbbVie, Inc.
-2.80%85.622.2%$723.75m
BMYBristol-Myers Squibb Company
-0.18%53.421.4%$558.47m
LLYEli Lilly and Company
-2.13%112.281.0%$522.71m
NVSNovartis AG Sponsored ADR
2.32%88.970.2%$285.46m
AZNAstraZeneca PLC Sponsored ADR
-0.24%40.241.3%$205.74m
GSKGlaxoSmithKline plc Sponsored ADR
-0.22%40.540.2%$130.41m
SNYSanofi Sponsored ADR
0.12%44.720.2%$67.60m
NVONovo Nordisk A/S Sponsored ADR Class B
1.47%44.280.1%$64.33m
LCILannett Company, Inc.
3.95%6.0337.0%$12.26m
AKTXAkari Therapeutics Plc Sponsored ADR
1.32%1.671.7%$0.04m

Company Profile

Lannett Co., Inc. engages in the development, manufacture, marketing, and distribution of generic pharmaceutical products. Its products include aqueous vitamin D 4; escitalopram oxalate; ranitidine syrup; danazol; primidone; and isonlazid. The company was founded in 1942 and is headquartered in Philadelphia, PA.